Hrt Financial LP Summit Therapeutics Inc. Transaction History

Hrt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$1.38 - $5.41 $496,078 - $1.94 Million	359,477 Added 935.5%	397,903 $696,000
Q4 2022 Feb 10, 2023	BUY	$0.68 - $5.31 $26,129 - $204,042	38,426 New	38,426 $163,000
Q2 2021 Aug 16, 2021	SELL	$5.15 - $8.46 $154,015 - $253,004	-29,906 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.17 - $11.19 $154,614 - $334,648	29,906 New	29,906 $175,000
Q4 2020 Feb 16, 2021	SELL	$3.25 - $6.0 $58,886 - $108,714	-18,119 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.08 - $3.8 $55,806 - $68,852	18,119 New	18,119 $62,000

192

75.8M

2.01M

2.84M

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $3.6B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.